Search

Author/Creator Linette, Gerald P.

1. 4473 Immune control of plasma cell disorders – in-depth analysis of Sox2 immunity in MGUS. Issue Volume 4:Issue(2020)Supplement 1 (June 2020)

Authors:
Susanibar Adaniya, Sandra Patricia; Cummins, Casey L.; Baroja, Miren L.; Carreno, Beatriz; Linette, Gerald P.; Garfall, Alfred L.; Robnett, Maya G.
Journal:
Journal of clinical and translational science
Issue:
Volume 4:Issue(2020)Supplement 1
Page Start:
136
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A Phase I Study of Apolizumab, an Anti-HLA-DR ß-chain Monoclonal Antibody, in Patients With Solid Tumor Malignancies. (1st July 2022)

Authors:
Fracasso, Paula M.; Goodner, Sherry A.; Wildi, Jonathan D.; Naughton, Michael J.; Linette, Gerald P.; Govindan, Ramaswamy; Tan, Benjamin R.; Blum, Kristie A.; Jones, Gary J.; Pearce, Tillman E.; Levitt, Daniel J.; Clamon, Gerald H.
Journal:
American journal of clinical oncology
Issue:
Volume 45:Number 7(2022)
Page Start:
294
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Histopathologic characteristics of therapy‐associated cutaneous neoplasms with vemurafenib, a selective BRAF kinase inhibitor, used in the treatment of melanoma. (29th April 2014)

Authors:
Sufficool, Kari E.; Hepper, Donna M.; Linette, Gerald P.; Hurst, Eva A.; Lu, Dongsi; Lind, Anne C.; Cornelius, Lynn A.
Journal:
Journal of cutaneous pathology
Issue:
Volume 41:Number 7(2014:Aug.)
Page Start:
568
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Phase 2 study of sunitinib in patients with metastatic mucosal or acral melanoma. Issue 22 (11th August 2015)

Authors:
Buchbinder, Elizabeth I.; Sosman, Jeffrey A.; Lawrence, Donald P.; McDermott, David F.; Ramaiya, Nikhil H.; Van den Abbeele, Annick D.; Linette, Gerald P.; Giobbie‐Hurder, Anita; Hodi, F. Stephen
Journal:
Cancer
Issue:
Volume 121:Issue 22(2015)
Page Start:
4007
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Vemurafenib treatment for patients with locally advanced, unresectable stage IIIC or metastatic melanoma and activating exon 15 BRAF mutations other than V600E. Issue 6 (December 2017)

Authors:
Hallmeyer, Sigrun; Gonzalez, Rene; Lawson, David H.; Cranmer, Lee D.; Linette, Gerald P.; Puzanov, Igor; Taback, Bret; Cowey, C. Lance; Ribas, Antoni; Daniels, Gregory A.; Moore, Timothy; Gibney, Geoffrey T.; Tawbi, Hussein; Whitman, Eric; Lee, Geraldine; Mun, Yong; Liu, Shiyao; Hamid, Omid
Journal:
Melanoma research
Issue:
Volume 27:Issue 6(2017)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗